0001313697-17-000003.txt : 20170530 0001313697-17-000003.hdr.sgml : 20170530 20170526182032 ACCESSION NUMBER: 0001313697-17-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170530 DATE AS OF CHANGE: 20170526 EFFECTIVENESS DATE: 20170530 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Theranos Inc CENTRAL INDEX KEY: 0001313697 IRS NUMBER: 201231826 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-287627 FILM NUMBER: 17875236 BUSINESS ADDRESS: STREET 1: 1701 PAGE MILL ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 650-838 9292 MAIL ADDRESS: STREET 1: 1701 PAGE MILL ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 D 1 primary_doc.xml X0707 D LIVE 0001313697 Theranos Inc 1701 PAGE MILL ROAD PALO ALTO CA CALIFORNIA 94304 650-838 9292 DELAWARE RealTime Cures, Inc. None Corporation true Elizabeth Anne Holmes 1701 Page Mill Road Palo Alto CA CALIFORNIA 94304 Executive Officer Director Fabrizio Bonanni 1701 Page Mill Road Palo Alto CA CALIFORNIA 94304 Director William Foege 1701 Page Mill Road Palo Alto CA CALIFORNIA 94304 Director Daniel Warmenhoven 1701 Page Mill Road Palo Alto CA CALIFORNIA 94304 Director Biotechnology Decline to Disclose 06b false 2017-05-15 false true false 0 582200318 582200318 0 Total offering amount represents the aggregate original issue price of the securities tendered in the Issuer's exchange offer with existing holders of its preferred stock. false 34 0 0 0 false Theranos Inc /s/ Elizabeth Holmes Elizabeth Holmes Chief Executive Officer 2017-05-25